Adult-onset Still’s disease (AOSD) is a rare, polygenic autoinflammatory syndrome with a pathogenesis similar to systemic juvenile inflammatory arthritis. Join Drs. Petros Efthimiou and Olga Petryna as they discuss making the diagnosis of AOSD through interpretation of clinical and laboratory findings and careful exclusion of other diseases. The faculty review the evidence related to the variety of medications often used to treat patients with AOSD, focusing on canakinumab, the only medication approved in the United States for the disease.
Show More
Creators & Guests
We don't know anything about the creators of this podcast yet. You can so they can be credited for this and other podcasts.
This podcast hasn't been reviewed yet. You can to show others what you thought.
Mentioned In These Lists
There are no lists that include "Exploring Best Practices for Diagnosis & Management of Adult-Onset Still's Disease". You can add this podcast to a new or existing list.
Host or manage this podcast?
Do you host or manage this podcast? Claim and edit this page to your liking.
Are we missing an episode or update? Use this to check the RSS feed immediately.